BCR and posterior cortical atrophy: However, more-recent reports indicated that tumor focality did not predict the risk of BCR after an RP in men with clinically-localized PCa, even if the tumor involved both lobes of the prostate [32], suggesting that tumor focality might not be a suitable predictive marker for BCR in patients with organ-confined PCa.